{"DataElement":{"publicId":"2685226","version":"1","preferredName":"National Surgical Adjuvant Breast and Bowel Project Patient Inclusion Clinical Trial Eligibility Criteria Type","preferredDefinition":"the elements of a personal medical history which are necessary to allow an individual to participate in a specific clinical trial of a person who receives medical attention, care, or treatment in NSABP R-04, a clinical trials cooperative group supported by NCI.","longName":"NSABP_PT_INC_CTEC_TP","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"2685224","version":"1","preferredName":"National Surgical Adjuvant Breast and Bowel Project Patient Inclusion Clinical Trial Eligibility Criteria","preferredDefinition":"information relating to the elements of a personal medical history which are necessary to allow an individual to participate in a specific clinical trial of a person who receives medical attention, care, or treatment in a clinical trials cooperative group supported by NCI.","longName":"NSABP_PT_INCL_CTEC","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2404995","version":"1","preferredName":"National Surgical Adjuvant Breast and Bowel Project Patient","preferredDefinition":"The National Surgical adjuvant Breast and Bowel Project (NSABP) is a clinical trials cooperative group supported by the NCI. The group headquarters in Pittsburgh, Pennsylvania and has research sites at nearly 200 major medical centers, university hospitals, large oncology practice groups, and health maintenance organizations in the United States, Canada, Puerto Rico, and Australia. . In addition to funding from the NCI, which the NSABP has received since it began, the NSABP also receives support from other sources for ancillary studies, training, and educational programs.:A person who requires medical care.","longName":"C15818:C16960","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"National Surgical Adjuvant Breast and Bowel Project","conceptCode":"C15818","definition":"A clinical trials cooperative group supported by the NCI. The group headquarters in Pittsburgh, Pennsylvania and has research sites at nearly 200 major medical centers, university hospitals, large oncology practice groups, and health maintenance organizations in the United States, Canada, Puerto Rico, and Australia. In addition to funding from the NCI, which the NSABP has received since it began, the NSABP also receives support from other sources for ancillary studies, training, and educational programs.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Patient","conceptCode":"C16960","definition":"A person who receives medical attention, care, or treatment, or who is registered with medical professional or institution with the purpose to receive medical care when necessary.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"00AD61C3-444D-1BBC-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-09-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-09-14","modifiedBy":"ONEDATA","dateModified":"2005-09-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2518229","version":"1","preferredName":"Inclusion Clinical Trial Eligibility Criteria","preferredDefinition":"The addition of somebody or something to, or the presence of somebody or something in, a group or mixture, particularly, a passive, usually temporary, product of cell activity within the cytoplasm or nucleus.:Elements of a personal medical history which are necessary to allow an individual to participate in a specific clinical trial.","longName":"C25532:C16112","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Inclusion Criteria","conceptCode":"C25532","definition":"Medical and/or social characteristics which are necessary for a subject to be allowed to participate in a clinical study, as outlined in the study protocol. Meeting inclusion criteria is not a sufficient condition for entry or recruitment of a subject into the study. Characteristics limiting the eligibility of a subject for the clinical study must be considered.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Clinical Trial Eligibility Criteria","conceptCode":"C16112","definition":"Characteristics which are necessary to allow a subject to participate in a clinical study, as outlined in the study protocol. The concept covers inclusion and exclusion criteria.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1CC96D39-08D4-6793-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-09-06","endDate":null,"createdBy":"SHIDED","dateCreated":"2006-09-06","modifiedBy":"ONEDATA","dateModified":"2006-09-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008525","version":"1","preferredName":"Eligibility","preferredDefinition":"trial-specific criteria that a patient must meet to be enrolled.","longName":"ELIG","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1EC3968-9F25-305A-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-16","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-16","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3B9897B3-CCC1-5406-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-10-03","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-10-03","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2685225","version":"1","preferredName":"R-04 Inclusion Clinical Trial Eligibility Criteria Type","preferredDefinition":"the inclusion criteria for R-04.","longName":"R04_INC_CTEC_TP","context":"CTEP","contextVersion":"2.31","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"200","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Has the patient consented to participate in this study and signed and dated an approved consent form","valueDescription":"Has the patient consented to participate in this study and signed and dated an approved consent form","ValueMeaning":{"publicId":"2685238","version":"1","preferredName":"Has the patient consented to participate in this study and signed and dated an approved consent form","longName":"2685238","preferredDefinition":"Has the patient consented to participate in this study and signed and dated an approved consent form","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3B98F884-02F1-5023-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-10-03","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-10-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"3B98D39A-3F53-278B-E044-0003BA3F9857","beginDate":"2007-10-03","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-10-03","modifiedBy":"ONEDATA","dateModified":"2007-10-03","deletedIndicator":"No"},{"value":"Does the patient have clinically significant peripheral neuropathy at the time of randomization (defined in the CTCAE v3.0 as grade 2 or greater neurosensory or neuromotor toxicity)","valueDescription":"Does the patient have clinically significant peripheral neuropathy at the time of randomization (defined in the CTCAE v3.0 as grade 2 or greater neurosensory or neuromotor toxicity)","ValueMeaning":{"publicId":"2685232","version":"1","preferredName":"Does the patient have clinically significant peripheral neuropathy at the time of randomization (defined in the CTCAE v3.0 as grade 2 or greater neurosensory or neuromotor toxicity)","longName":"2685232","preferredDefinition":"Does the patient have clinically significant peripheral neuropathy at the time of randomization (defined in the CTCAE v3.0 as grade 2 or greater neurosensory or neuromotor toxicity)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3B992D47-F9BE-501B-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-10-03","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-10-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"3B9950B0-E3C0-501D-E044-0003BA3F9857","beginDate":"2007-10-03","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-10-03","modifiedBy":"ONEDATA","dateModified":"2007-10-03","deletedIndicator":"No"},{"value":"Does the patient have a tumor that is clinically Stage II or III and a diagnosis of adenocarcinoma of the rectum obtained by a biopsy technique which leaves the major portion of the tumor intact","valueDescription":"Does the patient have a tumor that is clinically Stage II or III and a diagnosis of adenocarcinoma of the rectum obtained by a biopsy technique which leaves the major portion of the tumor intact","ValueMeaning":{"publicId":"2685233","version":"1","preferredName":"Does the patient have a tumor that is clinically Stage II or III and a diagnosis of adenocarcinoma of the rectum obtained by a biopsy technique which leaves the major portion of the tumor intact","longName":"2685233","preferredDefinition":"Does the patient have a tumor that is clinically Stage II or III and a diagnosis of adenocarcinoma of the rectum obtained by a biopsy technique which leaves the major portion of the tumor intact","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3B98ED75-0E20-2162-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-10-03","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-10-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"3B9950B0-E3D2-501D-E044-0003BA3F9857","beginDate":"2007-10-03","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-10-03","modifiedBy":"ONEDATA","dateModified":"2007-10-03","deletedIndicator":"No"},{"value":"Has the patient received any therapy for this cancer prior to randomization or had prior pelvic radiation for any reason","valueDescription":"Has the patient received any therapy for this cancer prior to randomization or had prior pelvic radiation for any reason","ValueMeaning":{"publicId":"2685234","version":"1","preferredName":"Has the patient received any therapy for this cancer prior to randomization or had prior pelvic radiation for any reason","longName":"2685234","preferredDefinition":"Has the patient received any therapy for this cancer prior to randomization or had prior pelvic radiation for any reason","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3B98EF26-764A-523D-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-10-03","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-10-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"3B9950B0-E3E4-501D-E044-0003BA3F9857","beginDate":"2007-10-03","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-10-03","modifiedBy":"ONEDATA","dateModified":"2007-10-03","deletedIndicator":"No"},{"value":"Does the patient have ischemic heart disease (class III or class IV myocardial disease - New York Heart Association), uncontrolled hypertension, symptomatic arrhythmia or a history of myocardial infarction within the past 6 months","valueDescription":"Does the patient have ischemic heart disease (class III or class IV myocardial disease - New York Heart Association), uncontrolled hypertension, symptomatic arrhythmia or a history of myocardial infarction within the past 6 months","ValueMeaning":{"publicId":"2685235","version":"1","preferredName":"Does the patient have ischemic heart disease (class III or class IV myocardial disease - New York Heart Association), uncontrolled hypertension, symptomatic arrhythmia or a history of myocardial infarction within the past 6 months","longName":"2685235","preferredDefinition":"Does the patient have ischemic heart disease (class III or class IV myocardial disease - New York Heart Association), uncontrolled hypertension, symptomatic arrhythmia or a history of myocardial infarction within the past 6 months","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3B990D4D-D6E5-527F-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-10-03","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-10-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"3B9950B0-E3F6-501D-E044-0003BA3F9857","beginDate":"2007-10-03","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-10-03","modifiedBy":"ONEDATA","dateModified":"2007-10-03","deletedIndicator":"No"},{"value":"Does the patient have psychiatric or addictive disorders that would preclude obtaining informed consent","valueDescription":"Does the patient have psychiatric or addictive disorders that would preclude obtaining informed consent","ValueMeaning":{"publicId":"2685236","version":"1","preferredName":"Does the patient have psychiatric or addictive disorders that would preclude obtaining informed consent","longName":"2685236","preferredDefinition":"Does the patient have psychiatric or addictive disorders that would preclude obtaining informed consent","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3B97F442-7621-56F9-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-10-03","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-10-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"3B9950B0-E408-501D-E044-0003BA3F9857","beginDate":"2007-10-03","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-10-03","modifiedBy":"ONEDATA","dateModified":"2007-10-03","deletedIndicator":"No"},{"value":"Has the patient authorized the release of Protected Health Information to the NSABP","valueDescription":"Has the patient authorized the release of Protected Health Information to the NSABP","ValueMeaning":{"publicId":"2685237","version":"1","preferredName":"Has the patient authorized the release of Protected Health Information to the NSABP","longName":"2685237","preferredDefinition":"Has the patient authorized the release of Protected Health Information to the NSABP","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3B990D4D-D6F5-527F-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-10-03","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-10-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"3B98D39A-3F41-278B-E044-0003BA3F9857","beginDate":"2007-10-03","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-10-03","modifiedBy":"ONEDATA","dateModified":"2007-10-03","deletedIndicator":"No"},{"value":"Does the surgeon consider the tumor to be amenable to curative resection","valueDescription":"Does the surgeon consider the tumor to be amenable to curative resection","ValueMeaning":{"publicId":"2685239","version":"1","preferredName":"Does the surgeon consider the tumor to be amenable to curative resection","longName":"2685239","preferredDefinition":"Does the surgeon consider the tumor to be amenable to curative resection","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3B98FA2D-325F-15C8-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-10-03","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-10-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"3B98D39A-3F65-278B-E044-0003BA3F9857","beginDate":"2007-10-03","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-10-03","modifiedBy":"ONEDATA","dateModified":"2007-10-03","deletedIndicator":"No"},{"value":"Does the patient have synchronous colon cancer","valueDescription":"Does the patient have synchronous colon cancer","ValueMeaning":{"publicId":"2685240","version":"1","preferredName":"Does the patient have synchronous colon cancer","longName":"2685240","preferredDefinition":"Does the patient have synchronous colon cancer","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3B97DC7F-66FF-5029-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-10-03","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-10-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"3B98D39A-3F77-278B-E044-0003BA3F9857","beginDate":"2007-10-03","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-10-03","modifiedBy":"ONEDATA","dateModified":"2007-10-03","deletedIndicator":"No"},{"value":"Has the patient had any prior malignancies in the past 5 years other than squamous or basal cell carcinoma of the skin, melanoma in situ, carcinoma in situ of the cervix , or carcinoma in situ of the colon or rectum that have been effectively treated","valueDescription":"Has the patient had any prior malignancies in the past 5 years other than squamous or basal cell carcinoma of the skin, melanoma in situ, carcinoma in situ of the cervix , or carcinoma in situ of the colon or rectum that have been effectively treated","ValueMeaning":{"publicId":"2685241","version":"1","preferredName":"Has the patient had any prior malignancies in the past 5 years other than squamous or basal cell carcinoma of the skin, melanoma in situ, carcinoma in situ of the cervix , or carcinoma in situ of the colon or rectum that have been effectively treated","longName":"2685241","preferredDefinition":"Has the patient had any prior malignancies in the past 5 years other than squamous or basal cell carcinoma of the skin, melanoma in situ, carcinoma in situ of the cervix , or carcinoma in situ of the colon or rectum that have been effectively treated","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3B98FDB4-A53C-4B56-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-10-03","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-10-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"3B98D39A-3F89-278B-E044-0003BA3F9857","beginDate":"2007-10-03","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-10-03","modifiedBy":"ONEDATA","dateModified":"2007-10-03","deletedIndicator":"No"},{"value":"Has the patient had a prior invasive rectal malignancy (regardless of the disease-free interval)","valueDescription":"Has the patient had a prior invasive rectal malignancy (regardless of the disease-free interval)","ValueMeaning":{"publicId":"2685242","version":"1","preferredName":"Has the patient had a prior invasive rectal malignancy (regardless of the disease-free interval)","longName":"2685242","preferredDefinition":"Has the patient had a prior invasive rectal malignancy (regardless of the disease-free interval)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3B9A0011-4AD1-0E93-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-10-03","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-10-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"3B97DC7F-6716-5029-E044-0003BA3F9857","beginDate":"2007-10-03","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-10-03","modifiedBy":"ONEDATA","dateModified":"2007-10-03","deletedIndicator":"No"},{"value":"Does the patient meet all other eligibility criteria","valueDescription":"Does the patient meet all other eligibility criteria","ValueMeaning":{"publicId":"2685243","version":"1","preferredName":"Does the patient meet all other eligibility criteria","longName":"2685243","preferredDefinition":"Does the patient meet all other eligibility criteria","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3B98EF26-765A-523D-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-10-03","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-10-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"3B97DC7F-6728-5029-E044-0003BA3F9857","beginDate":"2007-10-03","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-10-03","modifiedBy":"ONEDATA","dateModified":"2007-10-03","deletedIndicator":"No"},{"value":"Is the distal border of the tumor located less than 12 cm from the anal verge","valueDescription":"Is the distal border of the tumor located less than 12 cm from the anal verge","ValueMeaning":{"publicId":"2685244","version":"1","preferredName":"Is the distal border of the tumor located less than 12 cm from the anal verge","longName":"2685244","preferredDefinition":"Is the distal border of the tumor located less than 12 cm from the anal verge","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3B98EF26-766A-523D-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-10-03","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-10-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"3B97DC7F-673A-5029-E044-0003BA3F9857","beginDate":"2007-10-03","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-10-03","modifiedBy":"ONEDATA","dateModified":"2007-10-03","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008525","version":"1","preferredName":"Eligibility","preferredDefinition":"trial-specific criteria that a patient must meet to be enrolled.","longName":"ELIG","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1EC3968-9F25-305A-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-16","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-16","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2234813","version":"1","preferredName":"Type","preferredDefinition":"Type; a subdivision of a particular kind of thing.","longName":"C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F970CDF6-F90E-21D3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3B98DE99-3EDB-2CE3-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-10-03","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-10-03","modifiedBy":"SHIDED","dateModified":"2011-04-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008587","version":"2","longName":"Type of Disease","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811871","version":"1","longName":"Colorectal","context":"CTEP"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"CRF Text","type":"Preferred Question Text","description":"Eligibility Checklist","url":null,"context":"CTEP"}],"origin":"NSABP CRF:National Surgical Adjuvant Breast and Bowel Project Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"3B98E264-D740-15EC-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-10-03","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-10-03","modifiedBy":"CAMPBELB","dateModified":"2008-04-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}